TGFB1 and metabolic dysfunction-associated steatohepatitis: Several effects of vitamin E treatment have been reported in patients with NASH, such as reduced serum transaminase activities and TGF-β1, as well as hepatobiliary enzymes, hepatic steatosis, inflammation, and hepatocellular ballooning compared with the control group.